반응식
[NH:1]([C:3]1[N:8]([CH2:9][CH:10]([CH3:12])[CH3:11])[C:7](=[O:13])[N:6]([CH3:14])[C:5](=[O:15])[CH:4]=1)[NH2:2].[CH3:16][C:17]1[CH:25]=[CH:24][CH:23]=[C:22]2[C:18]=1[C:19]([CH:26]=O)=[CH:20][NH:21]2.[CH3:28][N:29]1[CH:33]=[CH:32][N:31]=[C:30]1[CH:34]=O>>[CH2:9]([N:8]1[C:3]2=[N:1][N:2]([CH2:26][C:19]3[C:18]4[C:22](=[CH:23][CH:24]=[CH:25][C:17]=4[CH3:16])[NH:21][CH:20]=3)[C:34]([C:30]3[N:29]([CH3:28])[CH:33]=[CH:32][N:31]=3)=[C:4]2[C:5](=[O:15])[N:6]([CH3:14])[C:7]1=[O:13])[CH:10]([CH3:11])[CH3:12]참가 물질
4
실험 절차
This compound was made following the procedure described above, starting with 6-hydrazino-1-isobutyl-3-methylpyrimidine-2,4(1H,3H)-dione, and condensing first with 4-methyl-1H-indole-3-carbaldehyde, followed by 1-methyl-1H-imidazole-2-carbaldehyde. Mass: 446.45 (M+H).
출처 및 근거
- ORD 기록
- ord-4fa8949c92d74c6e8b020eef2f846b58
- 출처 데이터셋
- uspto-grants-2007_10
- 특허 번호
- US07285558B2
연결된 노트
불러오는 중…